These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1197884)

  • 1. Prevention of myocardial generation in hamsters with hereditary cardiomyopathy.
    Jasmin G; Bajusz E
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():219-29. PubMed ID: 1197884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line.
    Jasmin G; Proschek L
    Muscle Nerve; 1982 Jan; 5(1):20-5. PubMed ID: 7057801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster.
    Kunkel B; Hofmann U; Mutschler M
    Z Kardiol; 1987; 76 Suppl 3():159-63. PubMed ID: 3501643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbed myocardial calcium metabolism: a possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster.
    Lossnitzer K; Janke J; Hein B; Stauch M; Fleckenstein A
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():207-17. PubMed ID: 1197882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic trials in hamster dystrophy.
    Jasmin G; Solymoss B; Proschek L
    Ann N Y Acad Sci; 1979; 317():338-48. PubMed ID: 289315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lercanidipine on coronary reactivity and myocardial remodeling in transition to heart failure in cardiomyopathic hamsters.
    Massicotte J; Viens A; Yao MH; Leonardi A; Sironi G; Wang H; Dumont L
    Acta Pharmacol Sin; 2003 Mar; 24(3):199-206. PubMed ID: 12617766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters.
    Paquette F; Jasmin G; Dumont L
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):525-30. PubMed ID: 10686662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function.
    Proschek L; Jasmin G
    Muscle Nerve; 1982 Jan; 5(1):26-32. PubMed ID: 7057802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of alkaline protease in the development of cardiac lesions in myopathic hamsters: effect of verapamil treatment.
    Kuo TH; Ho KL; Wiener J
    Biochem Med; 1984 Oct; 32(2):207-15. PubMed ID: 6391477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hereditary cardiomyopathy in the hamster by verapamil and other agents.
    Jasmin G; Solymoss B
    Proc Soc Exp Biol Med; 1975 May; 149(1):193-8. PubMed ID: 1144427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster.
    Rouleau JL; Chuck LH; Hollosi G; Kidd P; Sievers RE; Wikman-Coffelt J; Parmley WW
    Circ Res; 1982 Mar; 50(3):405-12. PubMed ID: 6460569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key role of Ca in the production of noncoronarogenic myocardial necroses.
    Fleckenstein A; Kanke J; Döring HJ; Leder O
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():21-32. PubMed ID: 1197883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
    Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
    Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy.
    Factor SM; Cho SH; Scheuer J; Sonnenblick EH; Malhotra A
    J Am Coll Cardiol; 1988 Dec; 12(6):1599-604. PubMed ID: 2973484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.
    Cohn RD; Durbeej M; Moore SA; Coral-Vazquez R; Prouty S; Campbell KP
    J Clin Invest; 2001 Jan; 107(2):R1-7. PubMed ID: 11160141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
    Factor SM; Minase T; Cho S; Dominitz R; Sonnenblick EH
    Circulation; 1982 Aug; 66(2):342-54. PubMed ID: 7094244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype.
    D'hahan N; Taouil K; Janmot C; Morel JE
    Br J Pharmacol; 1998 Feb; 123(4):611-6. PubMed ID: 9517378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction of isoproterenol-induced myocardial Ca uptake and necrotization in rats by a new Ca-antagonistic compound (ethyl-4-(3,4,5-trimethoxycinnamoyl) piperazinyl acetate (Vascordil)).
    Sigel H; Janke J; Fleckenstein A
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():121-6. PubMed ID: 1197874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological investigations in hamsters of strain BIO 8262 with hereditary myopathy and cardiomyopathy (author's transl)].
    Mohr W; Lossnitzer K
    Beitr Pathol; 1974; 153(2):178-93. PubMed ID: 4447589
    [No Abstract]   [Full Text] [Related]  

  • 20. Verapamil sensitizes cardiomyopathic hamsters to the effects of stress.
    Tapp WN; Natelson BH
    Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):511-4. PubMed ID: 3222529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.